Coya Therapeutics (COYA) Total Current Liabilities (2021 - 2026)
Coya Therapeutics (COYA) posted Total Current Liabilities of $3.5 million for Q1 2026, down 39.6% sequentially from $5.9 million in Q4 2025, and down 18.3% YoY from $4.3 million in Q1 2025.
Coya Therapeutics (COYA) Total Current Liabilities (2021 - 2026) Analysis & Trends
Coya Therapeutics has reported Total Current Liabilities for 6 years, with the latest figure at $3.5 million in Q1 2026.
- Quarterly Total Current Liabilities fell 18.3% year-over-year to $3.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.5 million (down 18.3% YoY) and the FY2025 annual result came in at $5.9 million, up 53.53% from the prior year.
- Total Current Liabilities declined to $3.5 million in Q1 2026 per COYA's latest filing, from $5.9 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $5.9 million in Q4 2025 and troughed at $1.2 million in Q2 2023.
- A 5-year average of $3.5 million and a median of $3.8 million in 2022 frame the typical range for Total Current Liabilities.
- The widest YoY moves for Total Current Liabilities: up 241.05% in 2024, down 24.3% in 2024.
- Over 5 years, Total Current Liabilities stood at $3.8 million in 2022, then jumped by 32.13% to $5.1 million in 2023, then decreased by 24.3% to $3.8 million in 2024, then surged by 53.53% to $5.9 million in 2025, then slumped by 39.6% to $3.5 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $3.5 million, $5.9 million, and $3.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.51 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 2.49 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 438.74 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 630.93 Mn |
| 10 | Coya Therapeutics | 113.53 Mn | 70.33 Mn | - | 3.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.51 Mn |
| Mar 31, 2026 | 3.55 Mn |
| Dec 31, 2025 | 5.87 Mn |
| Sep 30, 2025 | 3.67 Mn |
| Jun 30, 2025 | 4.50 Mn |
| Mar 31, 2025 | 4.34 Mn |
| Dec 31, 2024 | 3.82 Mn |
| Sep 30, 2024 | 2.32 Mn |
| Jun 30, 2024 | 3.83 Mn |
| Mar 31, 2024 | 4.32 Mn |
| Dec 31, 2023 | 5.05 Mn |
| Sep 30, 2023 | 1.81 Mn |
| Jun 30, 2023 | 1.22 Mn |
| Mar 31, 2023 | 1.27 Mn |
| Dec 31, 2022 | 3.82 Mn |
| Dec 31, 2021 | 1.15 Mn |